CD4 and Miyoshi myopathy: Notably, the percentage of Th2/CD4+ cells in patients with MM was significantly lower than that in HCs (P = 0.00013), but the percentage of Th17/CD4+ cells was significantly higher in patients with MM than that in HCs (P = 0.002) (Figure 3A).